AVH 2.37% $2.47 avita medical inc.

question relating to trials, page-5

  1. 33,567 Posts.
    lightbulb Created with Sketch. 1762
    latest presentation out today gives no estimated date for end of trials sp is slipping I guess in response to that.
    A very poor outlook my Mr Dolphin to as no quantified targets for revenue generation for product portfolio.
    I will hold but wish I had not bought this in the first place as looks like company still run by boffins not entrepeneurs and sales personal.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.